Hyper Baric Oxygen Therapy (HBOT) for Spontaneous Osteonecrosis of the Knee

Safety and Efficacy of Hyper Baric Oxygen Therapy (HBOT) in Patients Presenting With Spontaneous Osteonecrosis of the Knee

Status

UNKNOWN

Phases

Phase 1

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01950858

Enrollment

Registered

2013-09-26

Start date

2012-05-31

Completion date

2015-08-31

Last updated

2013-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spontaneous Osteonecrosis of the Knee

Brief summary

safety and efficacy of Hyper Baric Oxygen (HBO) in patients presenting with spontaneous osteonecrosis of the knee

Interventions

BIOLOGICALWeight reduction

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

40 Months to 85 Years

Healthy volunteers

Inclusion criteria

* Age40-85 years * Diagnosis of Spontaneous osteonecrosis of the knee (SONK)in last month, Stage 1 or 2 by MRI.

Exclusion criteria

* Hyperbaric treatment (HBOT) in the last 2 years. * Any contraindication for HBOT * Pregnancy. * Inability to sign inform consent * Any contraindication for MRI

Design outcomes

Primary

Measure	Time frame	Description
Efficacy	6 weeks	Pain Reduction
Safety	end of HBOT	Number of Participants with Adverse Events during HBOT

Secondary

Measure	Time frame
Reduction In AVN size by MRI	6 weeks

Countries

Israel

Contacts

Primary ContactYiftah Beer, MD

yiftah.beer@gmail.com972-8-9779432

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026